Thomas F Gajewski

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 11

Top Topics

Atopic Dermatitis

Immune Response

Rheumatoid Arthritis Patients

Top Venues

Science (New York, N.Y.)

JCO precision oncology

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Kristen Mathias, Sherin Juliet Rouhani, Daniel Olson, Anne R Bass, Thomas F Gajewski, Pankti D Reid
Association Between Rheumatic Autoantibodies and Immune-Related Adverse Events. The oncologist (2023)
Daniel F Hayes, Roy S Herbst, Jonathan L Myles, Suzanne L Topalian, Sophia L Yohe, Naomi Aronson, Andrew M Bellizzi, Upal Basu Roy, Georganne Bradshaw, Robin H Edwards, Ehab A El-Gabry, Julia A Elvin, Thomas F Gajewski, Lisa Meier McShane, Matthew Oberley, Reena Philip, David L Rimm, Jason N Rosenbaum, Eric H Rubin, Lisa Schlager, Shimere W Sherwood, Mark D Stewart, Janis M Taube, Magdalena Thurin, Patricia Vasalos, Jordan Laser
Proceedings From the ASCO/College of American Pathologists Immune Checkpoint Inhibitor Predictive Biomarker Summit. JCO precision oncology 6 (2022)
Robin Reschke, Jason W Shapiro, Jovian Yu, Sherin Juliet Rouhani, Daniel J Olson, Yuanyuan Zha, Thomas F Gajewski
Checkpoint Blockade-Induced Dermatitis and Colitis Are Dominated by Tissue-Resident Memory T Cells and Th1/Tc1 Cytokines. Cancer immunology research 10 (10) (2022)
Priscilla S Briquez, Sherin Juliet Rouhani, Jovian Yu, Athalia R Pyzer, Jonathan A Trujillo, Haley L Dugan, Christopher T Stamper, Siriruk Changrob, Anne I Sperling, Patrick C Wilson, Thomas F Gajewski, Jeffrey A Hubbell, Melody A Swartz
Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity. Science advances 8 (40) (2022)
Robin Reschke, Thomas F Gajewski
CXCL9 and CXCL10 bring the heat to tumors. Science immunology 7 (73) (2022)
Liam F Spurr, Carlos A Martinez, Wenjun Kang, Mengjie Chen, Yuanyuan Zha, Robyn Hseu, Stanley I Gutiontov, William T Turchan, Connor M Lynch, Kelli B Pointer, Paul J Chang, Septimiu Murgu, Aliya N Husain, Brittany Cody, Everett E Vokes, Christine M Bestvina, Jyoti D Patel, Maximillian Diehn, Thomas F Gajewski, Ralph R Weichselbaum, Steven J Chmura, Sean P Pitroda
Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade. Nature cancer (2022)
Blake A Flood, Emily F Higgs, Shuyin Li, Jason J Luke, Thomas F Gajewski
STING pathway agonism as a cancer therapeutic. Immunological reviews 290 (1) (2020)
Garth W Strohbehn, Brian L Heiss, Sherin Juliet Rouhani, Jonathan A Trujillo, Jovian Yu, Alec J Kacew, Emily F Higgs, Jeffrey C Bloodworth, Alexandra Cabanov, Rachel C Wright, Adriana Koziol, Alexandra Weiss, Keith Danahey, Theodore G Karrison, Cuoghi C Edens, Iazsmin Bauer Ventura, Natasha N Pettit, Bhakti Patel, Jennifer Pisano, Mary E Strek, Thomas F Gajewski, Mark J Ratain, Pankti D Reid
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19. medRxiv : the preprint server for health sciences (2020)
Vyara Matson, Jessica Fessler, Riyue Bao, Tara Chongsuwat, Yuanyuan Zha, Maria-Luisa Alegre, Jason John Luke, Thomas F Gajewski
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science (New York, N.Y.) 359 (6371) (2018)
Laurence Zitvogel, Yuting Ma, Didier Raoult, Guido Kroemer, Thomas F Gajewski
The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies. Science (New York, N.Y.) 359 (6382) (2018)
Jason B Williams, Brendan L Horton, Yan Zheng, Yukan Duan, Jonathan D Powell, Thomas F Gajewski
The EGR2 targets LAG-3 and 4-1BB describe and regulate dysfunctional antigen-specific CD8+ T cells in the tumor microenvironment. The Journal of experimental medicine 214 (2) (2017)